1 / 3

Asia-Pacific Indapamide Market Size, Industry Trends, Share and Forecast 2020-2026

Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia-Pacific, including China, India, and Singapore.

mansi3210
Download Presentation

Asia-Pacific Indapamide Market Size, Industry Trends, Share and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific Indapamide Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Asia-Pacific Indapamide Market: https://www.omrglobal.com/request- sample/asia-pacific-indapamide-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia- Pacific, including China, India, and Singapore. For instance, in India, one in five young adults has high blood pressure, according to the data presented at the 70th Annual Conference of the Cardiological Society of India (CSI) held from November 22nd- 25th 2018. This equals to nearly 80 million adults, which is a significant proportion than the entire UK population. The risk factors for high blood pressure in the country were smoking, tobacco chewing, diabetes mellitus, and high cholesterol. This, in turn, increased the need for hypertension treatment in the region and further encourages the market growth. A https://www.omrglobal.com/industry-reports/asia-pacific-indapamide-market full Report of Asia-Pacific Indapamide Market is Available at: The Asia-Pacific indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions. Request a Free Sample of our Asia-Pacific Indapamide Market: https://www.omrglobal.com/request- sample/asia-pacific-indapamide-market Asia-Pacific Indapamide Market Segmentation By Product •1.25 MG •2.5 MG By Application •High Blood Pressure •Heart Failure •Others Regional Analysis •China

  3. •India •Japan •Rest of Asia-Pacific Company Profiles •ANI Pharmaceuticals, Inc. •Glenmark Pharmaceuticals Ltd. •Merck KGaA •Sandoz International GmbH •Sanofi S.A. •Shandong Yinfeida Pharmaceutical Co., Ltd. •Supra Chemicals •Suzhou Lixin Pharmaceutical Co., Ltd. •Taj Pharmaceuticals Ltd. •Torrent Pharmaceuticals Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/asia-pacific-indapamide-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related